SW
ABBV icon

SkyOak Wealth’s AbbVie ABBV Stock Holding History

SkyOak Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Hold
6,725
– – 0.28% 70
2026
Q1 		$1.46M Hold
6,725
– – 0.27% 73
2025
Q4 		$1.54M Hold
6,725
– – 0.28% 73
2025
Q3 		$1.56M Buy
6,725
+250
+4% +$50.9K 0.29% 69
2025
Q2 		$1.2M Hold
6,475
– – 0.24% 74
2025
Q1 		$1.36M Sell
6,475
-28
-0.4% -$5.44K 0.3% 68
2024
Q4 		$1.16M Buy
6,503
+86
+1% +$15.8K 0.25% 69
2024
Q3 		$1.27M Sell
6,417
-25
-0.4% -$4.67K 0.28% 68
2024
Q2 		$1.1M Hold
6,442
– – 0.26% 70
2024
Q1 		$1.17M Sell
6,442
-4,412
-41% -$760K 0.28% 71
2023
Q4 		$1.68M Buy
10,854
+1,000
+10% +$146K 0.44% 56
2023
Q3 		$1.47M Sell
9,854
-63
-0.6% -$9.25K 0.43% 58
2023
Q2 		$1.34M Sell
9,917
-700
-7% -$103K 0.38% 58
2023
Q1 		$1.69M Buy
10,617
+700
+7% +$107K 0.52% 50
2022
Q4 		$1.6M Sell
9,917
-300
-3% -$46K 0.54% 51
2022
Q3 		$1.37M Buy
10,217
+500
+5% +$71.7K 0.49% 55
2022
Q2 		$1.49M Buy
9,717
+73
+0.8% +$11.2K 0.51% 54
2022
Q1 		$1.56M Hold
9,644
– – 0.43% 62
2021
Q4 		$1.31M Buy
9,644
+4,172
+76% +$493K 0.33% 77
2021
Q3 		$590K Hold
5,472
– – 0.16% 116
2021
Q2 		$616K Sell
5,472
-250
-4% -$28.2K 0.16% 113
2021
Q1 		$640K Buy
5,722
+1,300
+29% +$139K 0.18% 111
2020
Q4 		$474K Sell
4,422
-38
-0.9% -$3.65K 0.15% 133
2020
Q3 		$391K Hold
4,460
– – 0.14% 134
2020
Q2 		$438K Buy
4,460
+1,132
+34% +$99.7K 0.16% 138
2020
Q1 		$254K Sell
3,328
-1,206
-27% -$103K 0.13% 174
2019
Q4 		$401K Buy
+4,534
New +$376K 0.12% 195

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SkyOak Wealth's ABBV Position: Q2 2026 in Review

SkyOak Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 6,725 shares worth $1.69M. The position accounts for 0.28% of the portfolio, ranked #70.

SkyOak Wealth first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SkyOak Wealth held 6,725 shares of AbbVie worth $1.69M as of Q2 2026.
  • SkyOak Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.28% of SkyOak Wealth's portfolio in Q2 2026, its #70 holding.
  • SkyOak Wealth first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SkyOak Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.